The University Hospital of North Norway or UNN is a hospital and health trust. UNN is a university hospital for the region which includes the counties of Nordland, Troms and Finnmark. It is part of the Northern Norway Regional Health Authority. Its service area has a combined population of 465,000.

During the past decade, University Hospital of North Norway conducted 116 clinical trials. In the 10-year time frame, 116 clinical trials started and 1 clinical trials were completed, i.e. on average, 0.9% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 1 clinical trials were completed. i.e. 2.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital of North Norway" #1 sponsor was "University Hospital of North Norway" with 64 trials, followed by "Oslo University Hospital" with 18 trials sponsored, "University of Tromso" with 15 trials sponsored, "Haukeland University Hospital" with 7 trials sponsored and "Norwegian University of Science and Technology" with 7 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of North Norway" #1 collaborator was "University Hospital of North Norway" with 42 trials as a collaborator, "St. Olavs Hospital" with 30 trials as a collaborator, "Haukeland University Hospital" with 26 trials as a collaborator, "University of Tromso" with 23 trials as a collaborator and "Oslo University Hospital" with 15 trials as a collaborator. Other collaborators include 336 different institutions and companies that were collaborators in the rest 187 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of North Norway" are "Pain" (4 trials), "Prostate Cancer" (4 trials), "Rectal Cancer" (3 trials), "Stroke" (3 trials) and "Vitamin D Deficiency" (3 trials). Many other conditions were trialed in "University Hospital of North Norway" in a lesser frequency.

Most popular intervention types in "University Hospital of North Norway" are "Drug" (56 trials), "Other" (40 trials), "Procedure" (26 trials), "Behavioral" (13 trials) and "Device" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Cyclophosphamide" (4 trials), "Cholecalciferol" (3 trials), "Vincristine" (3 trials) and "cholecalciferol" (3 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of North Norway" are 143 trials for "All" genders, 12 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 66 active trials in "University Hospital of North Norway". 1 are not yet recruiting, 46 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 77 completed trials in University Hospital of North Norway, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of North Norway, 5 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 16 trials, and there were also 66 trials that are defined as “Not Applicable".